NCT03521310

Brief Summary

The World Health Organization recommend all stable low birth weight neonates to have Skin-to-skin-Contact (SSC) after birth. Intermittent SSC is used in Sweden in neonatal units. Observations indicate that SSC makes neonates feel good. However, there is limited research done on SSC treatment on neonates born prior to week 33. The aim of this study is to investigate whether Skin-to-skin-Contact (SSC) leads to an improved physiological stabilization, altered epigenetic profile and improved longterm psychomotor outcome in neonates born in gestation age between week 28+0 - 32+6. This is a parallel, two-arm, multicentre, randomized controlled superiority trial. The two arms to be compared are a) immediate SSC with one parent/caregiver continous during the first 6 hours after birth and as much as possible during the first 72 hours, and b) conventional method of care during the same time.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 11, 2018

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 12, 2021

Completed
Last Updated

January 6, 2022

Status Verified

December 1, 2021

Enrollment Period

3.5 years

First QC Date

February 20, 2018

Last Update Submit

December 16, 2021

Conditions

Keywords

IPISTOSSSkin to skinSSCNeonatalkangaroo mother care

Outcome Measures

Primary Outcomes (1)

  • Cardiorespiratory stability

    Using the Stability of the CardioRespiratory system In the Preterm-score (SCRIP-score). A higher SCRIP score indicates greater physiological stability

    After six hours

Secondary Outcomes (32)

  • Need for respiratory support

    After 3 months

  • Need for surfactant

    After 3 months

  • Need of Continuous positive airway pressure

    After 3 months

  • Need for oxygen

    After 3 months

  • Heart Rate Variability

    Up to 3-4 months

  • +27 more secondary outcomes

Study Arms (2)

Skin-to-skin Contact group

EXPERIMENTAL

Neonates in gestational age between 28+0 - 32+6 will get continuous Skin-to-skin contact with one parent/caregiver the first 6 hours after birth and as much as possible the first 72 hours after birth.

Procedure: Skin-to-skin

Conventional care group

ACTIVE COMPARATOR

Neonates in gestational age between 28+0 - 32+6 will get Conventional care - incubators, warmers etc - the first 72 hours after birth.

Procedure: Conventional care

Interventions

Skin-to-skinPROCEDURE

Neonates will get Skin-to-skin Contact with parent/caregiver continuously the first 6 hours after birth and as much as possible the first 72 hours after birth.

Skin-to-skin Contact group

Neonates will get Conventional care the first 72 hours after birth

Conventional care group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Born in gestation week plus days 28+0 - 32+6.
  • Born at maternity ward at study center
  • Consent from parents/caregivers
  • Parent or caregiver or substitute are available to start skin-to-skin Contact during the first hour of life.

You may not qualify if:

  • Born outside the hospital
  • Triplets or more
  • Known malformation which will require immediate surgical action
  • On-going resuscitation or intensive Medical care (mechanic ventilation or inotropy) after the first lifespan
  • \* Known congenital infection
  • Parent/care giver can not communicate in Swedish/Norwegian or English
  • Not suited for the study for other reasons (according to the principal investigator)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Stavanger University Hospital

Stavanger, Norway

Location

Department of Women´s and Children´s Health, Karolinska University Hospital

Stockholm, SE 171 77, Sweden

Location

Related Publications (2)

  • Lillieskold S, Lode-Kolz K, Rettedal S, Lindstedt J, Linner A, Markhus Pike H, Ahlqvist-Bjorkroth S, Aden U, Jonas W. Skin-to-Skin Contact at Birth for Very Preterm Infants and Mother-Infant Interaction Quality at 4 Months: A Secondary Analysis of the IPISTOSS Randomized Clinical Trial. JAMA Netw Open. 2023 Nov 1;6(11):e2344469. doi: 10.1001/jamanetworkopen.2023.44469.

  • Linner A, Westrup B, Lode-Kolz K, Klemming S, Lillieskold S, Markhus Pike H, Morgan B, Bergman NJ, Rettedal S, Jonas W. Immediate parent-infant skin-to-skin study (IPISTOSS): study protocol of a randomised controlled trial on very preterm infants cared for in skin-to-skin contact immediately after birth and potential physiological, epigenetic, psychological and neurodevelopmental consequences. BMJ Open. 2020 Jul 6;10(7):e038938. doi: 10.1136/bmjopen-2020-038938.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Björn Westrup, MD,PhD

    Department of Women´s and Children´s Health, Karolinska Institutet, Stockholm, Sweden

    STUDY CHAIR
  • Siren Rettedal, MD, PhD

    Stavanger University Hospital, Stavanger, Norway

    PRINCIPAL INVESTIGATOR
  • Wibke Jonas, Ass prof

    Department of Women´s and Children´s Health, Karolinska Institutet, Stockholm, Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Co-director of Karolinska NIDCAP Training and Research Center

Study Record Dates

First Submitted

February 20, 2018

First Posted

May 11, 2018

Study Start

April 1, 2018

Primary Completion

October 12, 2021

Study Completion

October 12, 2021

Last Updated

January 6, 2022

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations